| 骨质疏松症治疗药物研究概述 |
| |
| 引用本文： | 徐禄基,曹延广,许良,姚新苗. 骨质疏松症治疗药物研究概述[J]. 医学综述, 2009, 15(10): 1523-1525 |
| |
| 作者姓名： | 徐禄基 曹延广 许良 姚新苗 |
| |
| 作者单位： | 1. 浙江中医药大学研究生学院,杭州,310053
2. 浙江省针灸推拿医院骨伤科,杭州,310005 |
| |
| 摘 要： | 原发性骨质疏松症是以骨量减少、骨质微观结构退化为特征的一种全身性疾病。其主要并发症是各种脆性骨折,也是引起病残和死亡的主要原因。骨质疏松症已经成为严峻的公共卫生及社会问题。通过查阅国内外有关治疗骨质疏松症药物的文献报道,对近几年来抗骨质疏松症药物的研究进展进行综述,为临床防治骨质疏松症的医务工作人员做一有益参考。
|
| 关 键 词： | 骨质疏松 药物 骨密度 |
Development of Drugs in Treating Primary Osteoporosis |
| |
| XU Lu-ji,CAO Yan-guang,XU Liang,YAO Xin-miao. Development of Drugs in Treating Primary Osteoporosis[J]. Medical Recapitulate, 2009, 15(10): 1523-1525 |
| |
| Authors: | XU Lu-ji CAO Yan-guang XU Liang YAO Xin-miao |
| |
| Affiliation: | XU Lu-ji , CAO Yan-guang , XU Li- ang , YAO Xin-miao ( 1. Graduade School,Zhefiang University of Traditional Chinese Medicine,Hangzhou 310053, China ; 2. First Orthopedic Ward, Zhejiang Hospital of Acupuncture and Massage, Hang- zhou 310005, China) |
| |
| Abstract: | Primary osteoporosis is a systemic disease characterized by osteopenia and degeneration of hone mierostrueture. Its main complication are kinds of brittle bone fraeture,whiek also is the main reason resulting in disability and death. Osteoporosis has become the severe publie health and social problem. This article aims to providing a reference to clinical prevention and treatment of asteoporosis based on the related document of primary osteoporosis. |
| |
| Keywords: | Osteoporosis Drugs Bone mass density |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
